Background {#Sec1}
==========

Brucellosis, a disease caused by the bacteria of genus *Brucella* is a re-emerging zoonosis worldwide. This disease is highly prevalent in many regions, particularly in Central Asia, the Middle East, the Mediterranean region, Africa and Latin America \[[@CR1]\]. Brucellosis pose a major health concern in humans with initial clinical symptoms reported as fever, myalgia, malaise and may later develop into chronic disease affecting multiple organs \[[@CR2]\]. In the livestock industry, brucellosis cause significant reproductive losses in animals and subsequently causes great economic losses \[[@CR3]\]. Infection of *Brucella sp.* from animals to humans can occur by consumption of infected unpasteurised milk and dairy goods, inhalation of infected aerosolized particles and through direct contact with infected animal parts \[[@CR4]\].

Currently eleven species are recognized in the *Brucella* genus \[[@CR5]--[@CR9]\], four of which are known to infect humans. They are *Brucella melitensis, Brucella abortus, Brucella suis* and *Brucella canis* \[[@CR4]\]. In addition, *Brucella inopinata* was recovered from a human patient \[[@CR8]\]. Bacterial typing has seen a shift towards molecular identification using multiple-locus variable-number tandem repeat analysis (MLVA) as tools which is widely used in the study of *Brucella* species and other bacterial species of medical importance \[[@CR10]--[@CR13]\]. Based on the approach of high mutation rate in tandem DNA repeats loci, this important methodology has proven its discriminatory power in the study of *Brucella* species with high homogeneity and the ability to distinguish isolates of various geographic origins \[[@CR10], [@CR11]\]. MLVA typing has been useful in outbreak and epidemiological trace-back investigations and in confirming laboratory or foodborne acquired infections \[[@CR14]--[@CR18]\].

Malaysia, a small country located in Southeast Asia has reported cases of animal brucellosis but the percentage is lower compared to its neighbouring countries \[[@CR19]\]. The presence of brucellosis in the Malaysian livestock population has occurred for many decades although the seroprevalence is relatively low \[[@CR20]\]. In a recent study conducted from year 2000 to 2009, the seroprevalence of brucellosis among goats was detected throughout Malaysia but at generally low seroprevalences. The seroprevalence of brucellosis among goats was 0.91 % and among farms was 7.09 % \[[@CR21]\]. The seroprevalence of bovine brucellosis among cattle population in Malaysia was 21.8 % \[[@CR22]\]. No current data on the seroprevalence of porcine brucellosis is available except for data from 1955--56 which reported low titres of brucellosis among tested pig sera \[[@CR20]\].

In Malaysia, occupations associated with animals or animal related materials such as livestock workers, veterinarians and laboratory workers are most likely to be infected by brucellosis \[[@CR23], [@CR24]\]. Human brucellosis cases in Malaysia also occurred through consumption of unpasteurized goat milk \[[@CR25]\]. In a study among suspected human brucellosis cases, the seropositivity of brucellosis was only 5.4 % which suggests that the seroprevalence of brucellosis among individuals who have contact with infected animals in Malaysia is low \[[@CR26]\]. According to Ministry of Health Malaysia, less than five cases were reported in government hospitals between the year 2000 and 2008 \[[@CR27]\]. From year 2009 onwards, human brucellosis cases continued to be reported and most were sporadic cases. However, in the year 2011, an outbreak occurred in Penang, a state in the northern part of Malaysia with more than 30 cases being reported \[[@CR28]\]. There are limited studies on human brucellosis in Malaysia and to date no genotyping studies on the human *Brucella* isolates have been reported in Malaysia.

In this study, the MLVA assay was used to investigate the genetic diversity of both outbreak and sporadic human *Brucella* isolates collected between the year 2009 and 2014 to determine the genotype of isolates causing human brucellosis in Malaysia. To the best of our knowledge, this is the first genotyping study conducted in Malaysia for human *Brucella* isolates.

Methods {#Sec2}
=======

Ethics statement {#Sec3}
----------------

This study was carried out with the approval of Medical Research & Ethics Committee, Ministry of Health Malaysia in accordance to the International Conference of Harmonization Good Clinical Practice Guidelines (KKM/NIHSEC/08/0804/P11-666).

### *Brucella* isolates and DNA preparation {#Sec4}

A total of 45 isolates from human brucellosis cases in the year 2009--2014 were investigated. All samples were taken as part of standard care. Thirty-five isolates were outbreak cases occurring in the year 2011 while ten isolates were sporadic cases occurring between 2009 and 2014. All isolates were identified at the genus level based on classical identification tests such as Gram staining, positive oxidase and catalase tests, urease activity, dye sensitivity, agglutination with monospecific antisera for A and M antigens (Animal Health Veterinary Laboratories Agency, Weybridge, UK) and hydrogen sulfide production as described \[[@CR29]\]. Forty -- three isolates were identified as *Brucella melitensis* and two isolates were identified as *Brucella suis*. Total genomic DNA from these isolates were extracted using the DNeasy Blood and Tissue Kit (Qiagen, Hilden, Germany) and the DNA concentrations were measured using NanoDrop Spectrophotometer (Nanodrop Technologies, Wilmington, USA). *Brucella melitensis* 16 M was used as the control strain.

### Polymerase chain reaction (PCR) amplification and MLVA {#Sec5}

The sixteen sets of primers used in this MLVA assay were based on previously described methods \[[@CR10], [@CR11]\]. The 16 loci are categorized in three panels namely panels 1, 2A and 2B. Panel 1 composed of eight minisatellite loci (Bruce06, Bruce08, Bruce11, Bruce12, Bruce42, Bruce43, Bruce45, Bruce55) are used for species identification. Panel 1 also provides subspecies classification. The remaining three microsatellite loci in panel 2A (Bruce18, Bruce19, Bruce21) and five microsatellite loci in panel 2B (Bruce04, Bruce07, Bruce09, Bruce16, Bruce30) are used for further subspecies differentiation. All forward primers for each primer set except for Bruce07 and Bruce19 were synthesized with fluorescence dyes (FAM, HEX, or TAMRA). For Bruce07 and Bruce19, the primers were synthesized with either FAM or HEX as the reverse primer.

Monoplex PCR was performed in a total volume of 50 μl containing 10 ng of DNA, 0.3 μM of each primers and 25 μl of My Taq Mix, 2x (Bioline, London, UK). Amplifications were performed using an Eppendorf Mastercycler (Eppendorf AG, Hamburg, Germany) based on PCR conditions as previously reported \[[@CR10]\]. The amplified products were diluted between 1:50 to 1:300 with sterile deionised water. Denaturation of the samples were performed individually in microamp plates with a total volume of 10 μl containing 8.7 μl HI-DI formamide (Applied Biosystems, Lincoln City, USA), 0.3 μl GeneScan 1200 LIZ size standard (Applied Biosystems, Lincoln City, USA) and 1 μl of diluted amplified products at 95 °C for 5 min using an Eppendorf Mastercycler (Eppendorf AG, Hamburg, Germany). The denatured products were further resolved by capillary electrophoresis on an ABI 3730xl DNA analyzer (Applied Biosystems, Lincoln City, USA). Fragment sizes obtained were then analyzed using the GeneMapper software version 4.0 (Applied Biosystems, Lincoln City, USA).

### MLVA data analysis {#Sec6}

The copy number for each locus was managed as a character dataset using BioNumerics version 6.0 (Applied-Maths, Belgium). The clustering analysis was based on the categorical coefficient and Unweighted Pair Group Method Using Arithmetic Averages (UPGMA) method. The genotypes identified were compared with the isolates in the Brucella2012 MLVA database \[[@CR30]\]. The genetic diversity and confidence interval of each locus were calculated using the Hunter-Gaston Diversity Indices (HGDI) via an online tool V-DICE available at the HPA website \[[@CR31]\].

Results {#Sec7}
=======

Genotyping of human *Brucella melitensis* isolates using MLVA16 assay {#Sec8}
---------------------------------------------------------------------

The 43 *B. melitensis* isolates were shown to have genetic similarity coefficient ranging from 75.5 to 100.0 % (Fig. [1](#Fig1){ref-type="fig"}). Thirty-four isolates **(**cluster A2) shared the same MLVA16 genotype. Cluster A1 comprising two isolates differs at one locus (one repeat unit difference at the highly variable panel 2B locus Bruce04). The genetic similarity coefficient between cluster A1 and A2 is 93.8 %. These isolates were part of the outbreak strains that occurred in Penang in year 2011. Interestingly, isolate BRC7/11 which was from a patient from the state of Kedah, was shown to have 100.0 % similarity coefficient with the outbreak strains. This case was previously thought to be a sporadic case. The remaining isolates were from sporadic cases with similarity coefficient ranging from 75.5 to 87.5 %.Fig. 1Dendrogram for 43 *Brucella melitensis* isolates from cases of human brucellosis based on MLVA16 assay. Data indicated in the dendrogram: Strain name in the laboratory (Strain), complete panels (MLVA16) genotypes in this article (MLVA type), genotypes corresponding to each isolate in the Brucella2012 database (panel 1, panel 1 + 2A), species, state where the case was reported (Location) and year of isolation (Year)

Using panel 1, two genotypes were observed namely genotype 43 (42 isolates) and genotype 44 (one isolate). The genotypes 43 and 44 belonged to the East Mediterranean group \[[@CR11]\]. Further analysis with panel 1 and 2A revealed two genotypes, where the majority of the isolates were genotype 125 (42 isolates) followed by genotype 109 (1 isolate). Using the complete MLVA assay (panels 1, 2A and 2B), nine genotypes were obtained namely MLVA type M01 to MLVA type M09.

The increase in number of genotypes when using MLVA16 was the result of the high polymorphism displayed in panel 2B where Bruce04, Bruce16 and Bruce30 showed the highest discriminatory markers, with a diversity index of \> 0.17 harbouring 3, 4 and 7 alleles respectively (Table [1](#Tab1){ref-type="table"}). Among the three markers, Bruce04 shows the highest polymorphism. Bruce07 and Bruce09 with relatively small alleles (4 and 3 repeat units respectively) do not vary in the present collection. All panel 1 and panel 2A showed no diversity except Bruce08 of panel 1 which showed slight diversity, harbouring 2 alleles.Table 1Number of alleles and HGDI values of 43 isolatesLocusNumber of allelesNumber of repeatsHGDI^a^Confidence of IntervalPanel 1Bruce 06160.0000.000 - 0.151Bruce 0824, 50.0470.000 - 0.132Bruce 11130.0000.000 -- 0.151Bruce 121130.0000.000 -- 0.151Bruce 421420.0000.000 -- 0.151Bruce 431430.0000.000 -- 0.151Bruce 45130.0000.000 -- 0.151Bruce 55120.0000.000 -- 0.151Panel 2ABruce 18140.0000.000 -- 0.151Bruce 191410.0000.000 -- 0.151Bruce 21180.0000.000 -- 0.151Panel 2BBruce 0474, 6, 7, 8, 9, 10, 120.3740.193 -- 0.556Bruce 07140.0000.000 -- 0.151Bruce 09130.0000.000 -- 0.151Bruce 1635, 6, 70.1760.029 -- 0.324Bruce 3044, 6, 7, 80.2580.091 -- 0.425^a^Hunter --Gaston Diversity Index

Genotyping of human *Brucella suis* isolates using MLVA16 assay {#Sec9}
---------------------------------------------------------------

Two *B. suis* isolates from two sporadic cases showed 81.3 % in similarity (Fig. [2](#Fig2){ref-type="fig"}). Both *B. suis* isolates belonged to genotype 6 with isolate BRC3/09 showing closest relation to the *B. suis* biovar 1 group. The other *B. suis* isolate (BRC1/12) was not categorized in any group. MLVA11 shows isolate BRC3/09 and BRC1/12 belonged to genotype 33. Using the complete MLVA16 assay, two genotypes were obtained from the two *B. suis* isolates with the numbering of MLVA type M10 to MLVA type M11.Fig. 2Dendrogram for two *Brucella suis* isolates from cases of human brucellosis based on MLVA16 assay. Data indicated in the dendrogram: Strain name in the laboratory (Strain), complete panels (MLVA16) genotypes in this article (MLVA type), genotypes corresponding to each isolate in the Brucella2012 database (panel 1, panel 1 + 2A), species, state where the case was reported (Location) and year of isolation (Year)

Discussion {#Sec10}
==========

This is the first human brucellosis investigated using MLVA as the genotyping tools on 45 human *Brucella* isolates in Malaysia. Human brucellosis cases in this study were reported in seven states namely Perlis, Perak, Penang, Kedah (northern region), Selangor, Kuala Lumpur (federal territory) and Negeri Sembilan (central region). All the states were located in Peninsular Malaysia (Fig. [3](#Fig3){ref-type="fig"}). No human brucellosis cases were reported in the states of Sabah and Sarawak (East Malaysia). In our study, Penang had the highest reported cases of infection in humans by *B. melitensis* followed by the state of Selangor.Fig. 3Map of Malaysia showing states with reported case of human brucellosis (adapted from Google maps \[[@CR35]\])

Our findings most likely could be supported by a serosurveillance study conducted from 2000 to 2009 showing prevalence and distribution of zoonotic *B. melitensis* in goats which is higher in Peninsular Malaysia as compared to East Malaysia \[[@CR21]\]. From the same study, it was also found that infection of *B. melitensis* in goats is widespread among farms, affecting all 13 states and federal territories in Malaysia. The state of Perlis had the highest seroprevalence followed by Penang and Melaka. A recent study confirmed the presence of brucellosis in livestock by the isolation of *B. melitensis* in seropositive goats in Peninsular Malaysia \[[@CR32]\]. All the findings from these animal brucellosis studies are of importance in the epidemiology of human brucellosis in Malaysia.

Several studies have shown that *B. melitensis* is the most isolated *Brucella* species in human cases \[[@CR16], [@CR18]\]. This is in agreement with our findings as *B. melitensis* accounts for most of the cases reported in this study. Our data reveal that human brucellosis in Malaysia is highly-related to caprine infection as suggested by the clinical history of the patients.

Isolate BRC2/12 from a sporadic case reported in year 2012 shared similar MLVA profile as the 33 outbreak cases occurred in year 2011. This sporadic case was reported in the state of Penang and clinical history showed the patient consumed unpasteurised goat milk and the case is unrelated to the outbreak cases. Interestingly, in the outbreak cases, it was discovered that 33 patients consumed unpasteurised goat milk sourced from the same farm. All 33 isolates showed identical MLVA profiles (MLVA type M05) with good correlation with the epidemiological data. The MLVA assay also revealed that isolate BRC7/11 reported in Kedah, a state situated in the northern region was linked to the 32 cases reported in Penang indicating an outbreak from a common source of infection. However two of the isolates (BRC30/11 and BRC31/11) which were reported during similar outbreak period showed slight difference from the 33 outbreak isolates.

Both isolates BRC30/11 and BRC31/11 differed from the 33 isolates (MLVA type M05) at the bruce04 microsatellite locus from panel 2B by a difference of one repeat unit. Clinical history of isolate BRC30/11 indicated that the patient consumed unpasteurised goat milk during the outbreak period. Clustering analysis showed that isolates BRC30/11 and BRC31/11 were 93.8 % related to the 33 isolates of MLVA type M05, indicating that they are closely related. The two isolates did not share the same MLVA type which could be the result of mutation events in the course of outbreak. A study in Turkey also noted the same finding where two of the isolates yielded different MLVA profile from the outbreak isolates \[[@CR18]\].

High polymorphism is associated with some of the most variable loci in panel 2B (Bruce 04, Bruce16 and Bruce30) as observed in this study. The three highly variable loci of panel 2B were also observed in Turkish and Chinese isolates \[[@CR16], [@CR18]\]. MLVA16 assay has also been shown to have the ability to differentiate a new exposure from a relapse case in the same patient \[[@CR11]\]. In this study, isolates BRC26/11 and BRC33/11 from the outbreak were isolated from the same patient before treatment and after two months of completion of treatment respectively. Both isolates showed identical MLVA profile (MLVA type M05) implying that the patient most likely had a relapsed infection with the same strain of *B. melitensis*. To confirm this, whole genome sequencing analysis may provide a more definitive answer.

Isolate BRC5/10 was grouped in panel 1 genotype 44 and no clinical history was given for the patient who hails from Perlis, a state situated in the northern region of Malaysia. The panel 1 of MLVA16 assay indicated the isolate belonging to genotype 44 (1-4-3-13-3-2-3-2) clustered in the *Brucella melitensis* of East Mediterranean group. The panel 1 genotype 44 has been reported in Turkey and also present in Israel \[[@CR11], [@CR18]\].

*B. melitensis* has previously been clustered into three major lineages comprising the East Mediterranean, West Mediterranean and American group \[[@CR11]\]. *B. abortus* and *B. suis* have no prior groupings. Our results suggest that the *B. melitensis* isolates in Malaysia most likely form a homogenous group belonging to the East Mediterranean group. The data also showed that human *Brucella* isolates in Malaysia comprised of panel 1 genotypes 6, 43 and 44. Genotype 43 was also observed in other parts of the world including Turkey and China \[[@CR16], [@CR18]\]. Panel 1 genotypes 49 and 51 of *Brucella melitensis* in the Western Mediterranean group which are common in Italy \[[@CR11]\] were not detected in this study.

*B. suis* especially of biovars 1 and 3 are the causative agent of swine brucellosis in human and are commonly sporadic \[[@CR4]\]. In our study, *B. suis* infection also occurred among human patients. Both were sporadic cases reported in Penang and Negeri Sembilan. Isolate BRC1/12 originated from a single patient who works as a palm estate farmer and the case was reported in Penang. Even though he was not occupationally-involved in animals, he may have some contact with a close family member who was working in a pig slaughter farm. When queried upon the Brucella2012 database, the genotype did not cluster to any particular group and the isolate belonged to panel 1 genotype 6. Another isolate which was typed as *B. suis* was BRC3/09 which was identified in a patient in the state of Negeri Sembilan in the central region of Peninsular Malaysia. Isolate BRC3/09 also belonged to panel 1 genotype 6. Panel 1 genotyping identified the profile of both isolates as genotype 6 (2-3-6-11-3-1-5-2) which is closely related to *B. suis* biovar 1 group. The two *B. suis* isolates yielded MLVA11 genotype 33.

The presence of brucellosis in Malaysia was first documented in animals with the isolation of *Brucella abortus* in 1950 \[[@CR33]\], *Brucella suis* in 1960s \[[@CR33]\] and *B. melitensis* in 1994 \[[@CR23]\]. Subsequently, brucellosis was detected in humans in 1980 by the isolation of *B. suis* biotype 3 \[[@CR34]\] and in 1994 by the isolation of *B. melitensis* \[[@CR23]\]. The detection of *B. melitensis* and *B. suis* among Malaysian population decades ago still affect the current population today as shown in our data. One of the reasons of the continuous brucellosis infection in human population in Malaysia could be due to the animal reservoir. It is suspected that the annual mass importation of goats from endemic countries and importation of various breeding stocks of swines from Europe into Malaysia that causes the persistence of brucellosis in the animal population \[[@CR19]--[@CR21]\].

Our present study consists of 45 human isolates only. It is expected that more local isolates will be continuously studied to determine presence of new genotypes in the country, subsequently allowing for the genotyping results made accessible for querying and comparison to other *Brucella* isolates from wider geographical origins. Combined with new methodologies of whole genome sequencing, data obtained from analyses of MLVA11 genotype 125 from our present collection and from different parts of the world will be an important approach to the molecular epidemiological studies of *brucella* throughout the country as well as globally.

Conclusions {#Sec11}
===========

In conclusion, the results of the present study showed a low genetic diversity among *B. melitensis* and *B. suis* isolates from human patients. The genotypes found in Malaysia comprise mainly of panel 1 genotypes 43 and 44, grouped in *B. melitensis* of East Mediterranean while panel 1 genotype 6 belonged to the *B. suis* biovar 1 group. Panel 1 genotype 43 made up the most common genotype circulating in this country as observed in both outbreak and sporadic isolates. All the three panel 1 genotypes were confined to Peninsular Malaysia only since no cases of human brucellosis have been reported in Sabah and Sarawak (East Malaysia).
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